Simbi-M ® is a unique full-fledged high-protein easily digestible product of cellular nutrition, belongs to non-medicinal highly effective drugs for the prevention of diseases that have natural immunostimulating properties. It does not contain auxiliary components or preservatives.

According to the research results of the research Institute of nutrition of the Russian Academy of medical Sciences (Conclusion No. 72/e-121/4-13 dated 25.01.13), it was found that the protein-peptide material of the fermented milk product “Simbi-M®” more than 70% includes protein structures (oligopeptides, free amino acids), mainly low-molecular fractions, well absorbed in the gastrointestinal tract (GIT), present in colostrum of breast milk and milk of lactating animals, involved in providing innate immunity.


Colostrum peptides normalize metabolic processes in the body; “start” the process of cell rejuvenation; increase the protective forces of cells and their resistance to hypoxia; increase the body’s resistance to toxins; increase the efficiency of the body’s absorption of nutrients; improve the elimination of various toxins and metabolic products from the body; improve the functional activity of cells; optimize all recovery processes of the body; facilitate the work of the liver and pancreas, with subsequent purification of the liver ducts and restoration of liver functions.

Indications for use:

Violations of the physiological flora of the small and large intestines (during and after treatment with antibiotics or sulfonamides, chemo – and radiation therapy, surgery); digestive insufficiency syndrome, dyspepsia; diarrhea, flatulence, constipation; heartburn; gastroenteritis, colitis; senile bowel syndrome (chronic, atrophic gastroenteritis); disorders of the gastrointestinal tract caused by climate change, food poisoning; Hypo-and anacid conditions; enterogenic diseases of the gallbladder and liver; allergic skin diseases (including urticaria, endogenously caused chronic eczema); viral and infectious diseases; salmonellosis in the stage of convalescence (including in infants); consequences of medication; dysbiosis: violation of the microflora of the gastrointestinal tract, genitourinary organs, oral cavity;  hangover syndrome; immunodeficiency conditions; autoimmune (systemic) diseases; leukemia;

Simbi-M ® – is well tolerated by patients of any age, is not addictive, has no contraindications, and is hypoallergenic. Use during pregnancy and lactation is considered safe, necessary preventive and restorative for mother and child.


To strengthen the immune system, smooth out the increased sports, educational and seasonal loads of children and adults.


  • Simbi-M®. Colostrum peptides for complete cellular nutrition.
  • 60 tablets of 0.25 g
  • TU 9197-013-0080714072-2015
  • the technology for the production of peptides based on the symbiosis of beneficial bacteria is registered in the State register of inventions of the Russian Federation (Patent for invention No. 2524437 dated 04.06.2014).


Colostrum hydrolyzed by a symbiosis of bifido, lacto and other beneficial bacteria; colostrum peptides, amino acids, enzymes, vitamins, macro – and microelements.

usage Area:

For complex therapy of dysbiosis, immunodeficiency States, bronchopulmonary diseases, gastrointestinal diseases, Oncology. Eliminates allergies and side effects from the use of medicines, including herbal supplements.

Recommendations for use:

Adults 1 tablet 4 times a day, children 1 tablet 2 times a day before or during meals. It is recommended to take during pregnancy and lactation.


Simbi-M® has no contraindications, as the product is hypoallergenic, completely hydrolyzed to a low molecular weight peptide fraction, free amino acids. In this connection, there is no risk of Allergy to large proteins-immunoglobulins, Caseins.

Storage Conditions:

Shelf life-3 years. Store at a temperature of -20ºC to +40ºC and a relative humidity of no more than 85%.


There are no reviews yet.

Be the first to review “Simbi-M”

Your email address will not be published. Required fields are marked *